Skip to main content

Advertisement

Figure 2 | Annals of General Psychiatry

Figure 2

From: Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers

Figure 2

Mean scores on the Cigarette Withdrawal Scale (CWS). The figure shows the changes in the mean scores on the CWS over the 3-week study period in the group receiving placebo (placebo group), those receiving atomoxetine who completed the study (atomoxetine group), and those who received atomoxetine but dropped out during the study (last observation carried forward (LOCF) atomoxetine group). A two-sample t test demonstrated statistically significant difference (P < 0.05) between the atomoxetine group and placebo groups at 3 weeks (*).

Back to article page